SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(De Marzo Angelo M)
 

Search: WFRF:(De Marzo Angelo M) > A prospective study...

A prospective study of intraprostatic inflammation, focal atrophy, and progression to lethal prostate cancer

Zhang, Yiwen (author)
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston MA, USA
Zhou, Cindy Ke (author)
Epidemiology, Harvard T.H. Chan School of Public Health, Boston MA, USA
Rencsok, Emily M. (author)
Health Sciences & Technology, Harvard Medical School, Boston MA, USA
show more...
Fall, Katja, 1971- (author)
Örebro universitet,Institutionen för medicinska vetenskaper
Lotan, Tamara L. (author)
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore MD, USA
Loda, Massimo (author)
Pathologist-in-Chief, Weill Cornell Medicine, New York NY, USA
Giunchi, Francesca (author)
Pathology Unit, Addarii Institute, S. Orsola-Malpighi Hospital, Bologna, Italy
Platz, Elizabeth A. (author)
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore MD, USA
De Marzo, Angelo M. (author)
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore MD, USA
Mucci, Lorelei A (author)
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston MA, USA
Fiorentino, Michelangelo (author)
Pathology Service, University of Bologna, Bologna, Italy
Ebot, Ericka M. (author)
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston MA, USA
show less...
Department of Epidemiology, Harvard TH. Chan School of Public Health, Boston MA, USA Epidemiology, Harvard T.H. Chan School of Public Health, Boston MA, USA (creator_code:org_t)
American Association for Cancer Research, 2019
2019
English.
In: Cancer Epidemiology, Biomarkers and Prevention. - : American Association for Cancer Research. - 1055-9965 .- 1538-7755. ; 28:12, s. 2047-2054
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • BACKGROUND: Inflammation and focal atrophy are common features adjacent to prostate tumors. Limited evidence exists on whether these features have prognostic significance.METHODS: In the Health Professionals Follow-Up Study and Physicians' Health Study, we studied 1,035 men diagnosed with prostate cancer. A genitourinary pathologist centrally reviewed tumor and normal areas of hematoxylin and eosin slides from prostate cancer specimens for the presence of acute and chronic inflammation, and four subtypes of focal atrophy. Cox proportional hazards models adjusted for potential confounders were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for the association of these features with lethal prostate cancer, defined as development of metastatic disease or death during follow-up.RESULTS: During a median of 12 years of follow-up, 153 men developed lethal prostate cancer. Eighty-four percent of men had histologic evidence of chronic inflammation and 30% had acute inflammation. Both chronic and acute inflammation were inversely associated with lethal prostate cancer in age- and lifestyle-adjusted models. Chronic inflammation remained inversely associated with lethal prostate cancer after additionally adjusting for prognostic clinical features (HR=0.45, 95% CI 0.30 to 0.69 for mild, HR=0.51, 95% CI 0.33 to 0.80 for moderate to severe). None of the atrophic lesions were associated with lethal prostate cancer.CONCLUSIONS: Our data suggest that the presence of inflammation, particularly chronic inflammation, in prostate cancer tissue is associated with better prognosis among prostate cancer patients.IMPACT: This is the largest prospective cohort study to examine the association between inflammation, focal atrophy, and lethal prostate cancer.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view